학술논문
Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma.
Document Type
Journal Article
Author
Source
Subject
*RITUXIMAB
*CISPLATIN
*B cell lymphoma
*LYMPHOMAS
*NEPHROTOXICOLOGY
*ANTINEOPLASTIC agents
*CANCER relapse
*GLOMERULAR filtration rate
*TUMOR classification
*TREATMENT effectiveness
*DISEASE remission
*
*
*
*
*
*
*
*
*
*
Language
ISSN
1471-2407
Abstract